Neurona Therapeutics Stock
Neurona Therapeutics is a clinical-stage biotherapeutics company focused on developing regenerative neural cell therapies for chronic neurological disorders. It creates specific neuronal, glial, and gene-edited cell therapy candidates aimed at repairing dysregulated neural circuits and providing curative treatments.
Founded: 2008
For more Neurona Therapeutics stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Cory Nicholas Ph.D. Co-Founder & Chief Executive Officer |
| James Stutz Chief Financial Officer & Chief Business Officer |
| Gautam Banik Ph.D. Chief Technology Officer |
| Catherine Priest Ph.D. Chief Development Officer |
| Arturo Álvarez-Buylla Ph.D. Co-Founder & Scientific Advisor |
| John Rubenstein Ph.D. Co-Founder & Scientific Advisor |
| Arnold Kriegstein Ph.D. Co-Founder & Scientific Advisor |
| Manher Joshi MD Chief Medical Officer |
